Objective: Whereas sex differences in the pathogenesis, presentation, and outcomes of repair for abdominal aortic aneurysms are well studied, less is known about sex differences after thoracic endovascular aortic repair (TEVAR). The goal of this study was to evaluate the association between sex and morbidity and mortality after TEVAR.
Sex differences in outcomes after vascular surgery exist and are well described for abdominal aortic aneurysms, with female patients having higher rates of rupture and worse outcomes after both open and endovascular repair. [1] [2] [3] [4] [5] However, much less is known about sex differences in outcomes after repair of descending thoracic aortic aneurysms. 6, 7 Although several prospective trials have suggested sex differences, especially in vascular complications, after thoracic endovascular aortic repair (TEVAR), these have been secondary observations and not part of the primary study aim. [8] [9] [10] Institutional studies assessing sex differences after TEVAR have suggested no difference in mortality, although these were limited by small sample sizes. 11, 12 From One recent, large retrospective study of TEVAR using National Surgical Quality Improvement Program data showed female sex to be associated with increased 30-day mortality. 13 However, the association lost statistical significance after adjusting for intraoperative variables, including operative time and use of iliac artery exposure, suggesting that the mortality difference may be, in part, explained by varying aortoiliac and femoral arterial disease burden between sexes. Further investigation with aneurysm-and vascular-specific data is needed to better elucidate this relationship. Therefore, the goal of this study was to evaluate the relationship between sex and outcomes after TEVAR in a contemporary series, with focus on 30-day and long-term mortality.
METHODS
The Beth Israel Deaconess Medical Center Institutional Review Board approved this study and waived informed consent because of the use of deidentified data.
Population. This is a retrospective cohort study using the Society for Vascular Surgery Vascular Quality Initiative (VQI), which is a national clinical registry established as a collaboration between regional quality groups in an effort to improve patient care through the prospective collection of clinical data. At the time of this analysis, the VQI included 16 regions and >300 participating hospitals. Within participating hospitals, complete capture of all included procedures is expected, with regular performance reviews to ensure compliance. More information about the VQI can be found at www. vascularqualityinitiative.org. We identified all patients undergoing TEVAR for descending thoracic aortic aneurysm between 2011 and 2015 and excluded those with trauma (n ¼ 262), dissection (n ¼ 873), or rupture (n ¼ 305). As the TEVAR database in the VQI contains TEVAR and complex endovascular aneurysm repair (EVAR) patients, all complex EVAR patients were also excluded (n ¼ 699).
Variables. Demographics, comorbid conditions, operative details, and in-hospital postoperative outcomes were identified for all patients. Aortic diameter was defined by the VQI as the maximum total aortic diameter within the diseased segment being treated. Body mass index (BMI) and body surface area (BSA) were calculated for each patient using height and weight information. We used the standard formula for BMI: BMI ¼ weight (kg)/height (m 2 ); and we used the Dubois Take Home Message: In this VQI study of 2574 patients with elective thoracic endovascular aortic repair (TEVAR), both 30-day and 1-year mortality rates were higher in women than in men, and female sex was an independent predictor of mortality. Recommendation: These data recommend that female sex be considered an independent predictor of mortality after TEVAR.
identified on univariate analysis with P < .1 for each end point of interest and clinically relevant factors shown to be predictive of adverse events in previous studies. 17 Kaplan-Meier survival estimates were stratified by sex and compared by the log-rank test. All tests were conducted two sided, and a P value of < .05 was considered significant. Statistical analysis was conducted using Stata version 14.1 (StataCorp LP, College Station, Tex).
RESULTS

Demographics.
We identified 2574 patients who underwent TEVAR, of whom 40% (1038) were female. Women were slightly older than men (73 vs 72 years; P ¼ .03) and were less often white (75% vs 81%; P < .001; Table I ). Aortic diameter was smaller in female patients (5.8 cm vs 6.0 cm; P ¼ .02), but after accounting for body size, females had larger aortic size indices (3.2 cm/m 2 vs 2.8 cm/m 2 ; P < .001). Women were less likely to have known coronary artery disease (19% vs 26%; P < .001) or to have had prior coronary artery bypass grafting or percutaneous coronary intervention (15% vs 31%; P < .001). However, female patients were more likely to have chronic obstructive pulmonary disease (33% vs 28%; P ¼ .01) and preoperative anemia (20% vs 12%; P < .001). Women were less likely to have had any prior aortic intervention (23% vs 30%; P < .001). Female patients were also less likely to be fully independent at baseline (88% vs 93%; P < .001). There was no difference in rate of connective tissue disease, renal insufficiency, or diabetes (Table I ).
Operative details. Female patients were more likely to present symptomatically (16% vs 10%; P < .001) and subsequently were less likely to have an elective procedure (79% vs 85%; P < .001; Table II) . Intraoperatively, female patients were more likely to undergo iliac access procedures (4.3% vs 2.1%; P < .01). Of the types of iliac access performed, female patients were slightly more likely to undergo aortofemoral or iliofemoral bypass (1.2% vs 0.5%; P ¼ .06) and temporary conduit placement (1.0% vs 0.3%; P ¼ .03), but rates of percutaneous transluminal angioplasty/stent and stent graft placement were similar. Arm/neck access procedures and left subclavian interventions were performed at similar rates. The proximal and distal extents of disease were both slightly more distal in female patients (Table II; proximal, P ¼ .10; distal, P ¼ .04), but this analysis was limited by 70% missing data. Female patients were more likely to have an estimated blood loss >500 mL (20% vs 17%; P ¼ .04) and were also more likely to undergo intraoperative blood transfusion (29% vs 21%; P < .001). Whereas there was a trend toward reduced operative time in female patients (150 vs 161 minutes; P ¼ .08), this was not statistically significant. However, in the subset of patients who did not undergo iliac access procedures, females had significantly shorter operative times (146 vs 160 minutes; P ¼ .03). Female patients were slightly more likely to undergo conversion to open thoracic aortic repair (0.6% vs 0.2%; P ¼ .054), although this was not statistically significant and the rates in both groups were low.
Outcomes. Female patients were more likely than male patients to have a major adverse event (7.6% vs 4.3%; P < .001). Male and female patients had similar in-hospital postoperative rates of stroke, myocardial infarction, dysrhythmia, and pneumonia (Table III) . However, female patients were more likely to be reintubated (6.6% vs 4.7%; P ¼ .04), to be treated with new postoperative renal replacement therapy (0.8% vs 0.2%; P ¼ .03), and to be transfused postoperatively (29% vs 19%; P < .001). Female patients were much more likely to have spinal cord ischemia (4.0% vs 1.0%; P < .01), although there was 65% missing data with this variable. Female patients were also more likely to have an access artery injury (2.9% vs 1.2%; P < .01). Female patients had longer lengths of stay in both the intensive care unit (2.5 vs 2 days; P < .001) and the hospital (5 vs 4 days; P < .001). Even among patients with no complications, female patients had higher lengths of stay (4 vs 3 days; P < .001). Women were also more likely to be discharged to a skilled nursing facility (25% vs 14%; P < .001).
Unadjusted mortality was higher in female patients at 30 days (5.4% vs 3.3%; P < .01) and 1 year (12% vs 8.1%; log-rank, P < .01; Table III). After adjusting for age, aortic size index, symptom status, and comorbidities including statin use, female sex remained associated with 30-day mortality (odds ratio, 1.8; 95% confidence interval [CI], 1.1-2.9; P ¼ .01; Table IV ). Adding iliac access procedure to the model does not affect the relationship between sex and mortality (odds ratio, 1.8; 95% CI, 1.1-2.8; P ¼ .02). Kaplan-Meier estimates showed reduced survival in female patients compared with male patients (Fig) , with an 88% survival in female patients compared with 92% survival in male patients at a median followup time of 21 months. In addition, after Cox hazards modeling was used to adjust for age, aortic size index, symptom status, and comorbidities, female sex was still independently associated with mortality during followup (hazard ratio, 1.3; 95% CI, 1.01-1.8; P ¼ .046; Table V).
DISCUSSION
We found that female patients have higher 30-day and long-term mortality compared with male patients after TEVAR for intact descending thoracic aortic aneurysms. These associations persisted after adjusting for differences in age, comorbidities, and symptom status. The reason for this is likely to be multifactorial, but possible explanations include more complicated aortic or access vessel anatomy, higher rates of symptomatic aneurysms, worse baseline health, and other social impacts on health status. Women have been shown in multiple series to experience worse outcomes than men after open and endovascular repair of abdominal aortic aneurysms. 5, [18] [19] [20] However, few studies directly evaluated sex differences 8 the Gore TAG trial showed no trend, 9 although mortality in the latter population was very low at 1.2%, which has not been duplicated in subsequent studies. The population in the VQI, which consists of large academic medical centers as well as smaller community hospitals, is likely more generalizable to the real world. The sex differences we witnessed may be due to the fact that our cohort included patients with more medical and anatomic complexity than those seen in clinical trials, in which inclusion and exclusion criteria are stricter and procedures are limited to centers with demonstrated clinical expertise. Arnaoutakis et al used National Surgical Quality Improvement Program data from 2005 to 2011 to evaluate sex differences after TEVAR, and similar to our findings, they found that female patients had higher mortality. In contrast, however, they did not find female sex to be independently predictive of mortality after adjusting for differences in age, comorbidities, use of iliac access procedures, and operative time. The prospective clinical trials of the early Gore and Medtronic devices had similar findings, noting both increased use of iliac conduits and higher rates of access vessel injuries in female patients. 8, 9 These findings have also been demonstrated in the abdominal aortic aneurysm literature, in which a national study of >15,000 EVAR patients showed that women were significantly more likely to have an iliac conduit or direct iliac access (26% vs 18%; P ¼ .02), and iliac access, in turn, was associated with a nearly threefold increase in perioperative mortality. 21 On the basis of these results, we hypothesized that at least some of the sex differences could be explained by smaller, more diseased access vessels in female patients. Although we also found higher rates of iliac conduit use (4.3% vs 2.1%) and access artery injury (2.9% vs 1.2%), adjusting for conduit use did not completely account for the mortality difference in our cohort. Notably, rates of conduit use and access artery injury were much lower in both male and female patients than in prior studies, which may represent the use of contemporary, lower profile endografts as well as surgeons' experience. However, we do not have information in our data set about access vessel size or the type of endograft used to evaluate this further. We did find that female patients had higher rates of spinal cord ischemia, although conclusions from this are limited, given the high percentage of missing data. If all patients with missing data were assumed to have no spinal cord ischemia, female patients were still more likely to develop this complication (1.5% vs 0.3%; P < .01), but further study of this should be done to determine if this discrepancy does in fact exist and if it is related to increased degree of aortic coverage.
In addition to discrepancies in anatomy, female patients in this series were more likely to be symptomatic at presentation. This has been replicated in patients with abdominal aortic aneurysms, as women are more likely to present with symptoms or rupture. 19 Furthermore, we have seen in patients with abdominal aortic aneurysm that patients with intact but symptomatic aneurysms have worse outcomes than patients undergoing elective repair. 22 However, in our analysis, symptom status did not predict perioperative or longterm mortality, and even after adjusting for this, female sex was still predictive of mortality. Therefore, severity at presentation alone is not the only explanation for the mortality differences we identified. An alternative explanation for the mortality difference we identified may be the older age and increased medical complexity of the female patients undergoing TEVAR. We found that women were older and more often had chronic obstructive pulmonary disease. In addition, as noted in the thoracic and abdominal aortic aneurysm literature, 9,23 female patients were less likely to have coronary artery disease or prior coronary intervention. This may represent less coronary disease burden but could also mean that female patients have more undiagnosed disease, leading to increased perioperative cardiac complications. Notably, however, there were no differences in the postoperative rates of myocardial infarction or dysrhythmia in our series. Despite the worse 30-day and long-term mortality in women even after adjusting for age and comorbidity differences, there is likely to be some degree of unaccounted-for medical complexity or frailty that is contributing to this disparity. We also found that female patients were less likely to be functionally independent preoperatively and had longer hospital and intensive care unit lengths of stay, with increased discharge to a skilled nursing facility. Other studies of TEVAR showed similarly prolonged hospital lengths of stay in female patients. 8, 9, 13 Whereas the increased time in the hospital could be related to higher rates of complications, length of stay was longer even in patients with no postoperative complications. This, in conjunction with the higher rates of discharge to skilled nursing facilities, may be related to disparities in social factors, with more women perhaps playing the role of caregiver within their family, without a caregiver able to provide for them in return. These social factors, which are not included in the recorded variables, may also contribute to the mortality disparities seen in this study. The decision to repair an aortic aneurysm weighs the rupture risk, life expectancy, and morbidity and mortality risk associated with operative repair. Therefore, if female patients experience higher perioperative mortality, this should factor into the operative decision-making. Different aneurysm size thresholds by sex have been suggested in abdominal aortic aneurysms, given the higher rupture risk at smaller diameters in female patients. 24, 25 In addition, female patients in our study also had higher rates of chronic obstructive pulmonary disease, which is also known to correlate with rupture risk. 26 We have no data from this study regarding risk of rupture, but the operative mortality in female patients remained higher even after adjusting for aortic diameter and aortic size index. Further research is needed to determine the ideal threshold for repair, by either diameter or aortic size index, weighing the reduced life expectancy and increased operative burden with the potential rupture risk. These data must be interpreted in the context of the study design. Clinical registries often have incomplete data and limited variable definitions. In particular, long-term follow-up information in the VQI is limited, so we are unable to adequately account for late endoleak and reintervention or to determine if sex differences in late reinterventions contribute to the higher late mortality in female patients. In addition, only in-hospital perioperative outcomes are recorded, so readmissions are not captured and other postoperative complications may be under-reported, especially after an operation with a median hospital stay <1 week. Whereas the VQI does provide more granular data than other non-vascular-specific registries, it does not include information about presence of aortic thrombus, access vessel size, and certain concomitant procedures, such as multistage hybrid repairs. However, many of the variables we can measure can be used as surrogate markers for these findings, including the use of iliac access procedures for access vessel size. In addition, to fully understand disparities, social factors must be considered, and these variables are difficult to quantify or even to capture in any registry. Again, patient functional status and discharge status can be used as markers for these findings. Further study of sex differences after TEVAR are warranted to mitigate these disparities as best as possible.
CONCLUSIONS
Female patients have higher mortality than male patients after TEVAR in a real-world population, even after adjusting for their older age and increased medical comorbidities. Further research into the cause of these sex differences will allow us to determine the optimal threshold for repair of thoracic aortic aneurysms in female patients. 
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